Jacob Smith
25 Mar 2026
Biotech firm Abivax is planning to raise funds after releasing key tr… – Jacob Smith
Biotech firm Abivax is planning to raise funds after releasing key trial data, signaling strong confidence in its pipeline. The company says it is not rushing into a sale, keeping options open amid growing investor interest. #Biotech #Abivax #Healthcare #Investing #Pharma

25 Mar 20268 likes7 comments